Working Group on Designation Requirements for Core Hospitals for Cancer Genomic Medicine

News Highlights

The Ministry of Health, Labour and Welfare has released the discussion results from the “Working Group on Designation Requirements for Core Hospitals for Cancer Genomic Medicine.” This will strengthen the provision system for cancer genomic medicine, requiring core hospitals to possess more advanced clinical functions and research and development capabilities. The concretization of designation requirements is expected to influence the future functional differentiation and collaboration among medical institutions.

M&A Medical Editorial Perspective

The discussions of this “Working Group on Designation Requirements for Core Hospitals for Cancer Genomic Medicine” are rich in implications, not only in terms of advancing cancer treatment but also directly relating to the management strategies of medical institutions, particularly their positioning within regional healthcare. The requirements for core hospitals, such as “advanced clinical functions,” “research and development capabilities,” and “human resource development,” are likely to be limited to a few university hospitals and cancer centers in the current landscape. Medical institutions that receive this designation or collaborate with them will need to make considerable investments in facilities, secure personnel, and establish research systems. On the other hand, for medical institutions that cannot receive the designation or lack resources, this could be an opportunity to specialize in roles that leverage their strengths (e.g., initial diagnosis, palliative care, provision of standard treatments based on genomic information), strengthen collaboration with core hospitals, or even consider business restructuring through M&A. Particularly for regional hospitals anticipating future resource shortages, the tightening of these designation requirements will be an important factor in decision-making from the perspective of business continuity.

Points Raised by This News

• With the advancement of cancer genomic medicine, the functions required of core hospitals are being clarified, redefining the division of roles in regional healthcare.
• The tightening of designation requirements leads to increased burdens in facility investment and personnel acquisition, raising business continuity challenges, especially for regional medical institutions.
• Strengthening collaboration with core hospitals, specializing in functions that leverage a hospital’s own strengths, or considering business restructuring through M&A are becoming realistic options for some medical institutions.
• The evolution of genomic medicine has the potential to accelerate the reorganization of future healthcare provision systems, requiring healthcare executives to develop strategies early on.

Practical Questions Arising from This News

• What are the specific requirements for designation as a core hospital for cancer genomic medicine?
• What alternative strategies can be considered if designation is not possible?
• What schemes can be considered to deepen collaboration with core hospitals?

If You Feel “Should I Consult?”

Are you considering how your institution will incorporate the government’s policy trends for strengthening the cancer genomic medicine provision system into your management strategy? Options such as designation as a core hospital, collaboration, or specialization of your own institution’s functions will significantly impact future profitability and contribution to the region. If you are concerned about resource shortages or future business continuity, we recommend taking this opportunity to consult with experts and consider the optimal business succession and M&A strategy for your institution.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics with a full success fee, as an M&A support institution certified by the Small and Medium Enterprise Agency. Consultations are accepted with strict confidentiality. Free consultation here